TABLE 4.
Candidate mutation detection rates within experimental dyslipidemia cohorts
| Candidate Mutation |
||
| Disease | Positive | Negative |
| FH (%) (n = 19) | 8 (42.1) | 11 (57.9) |
| HTG (%) (n = 14) | 12 (85.7) | 2 (14.3) |
| MODY (%) (n = 2) | 1 (50) | 1 (50) |
| FPLD (%) (n = 2) | 0 (0) | 2 (100) |
| HBL (%) (n = 1) | 1 (100) | 0 (0) |
| Totala (%) (n = 38) | 22 (57.9) | 16 (42.1) |
FH patients previously screened for candidate mutations (n = 10) are not included here.